NEUROPHYSIOLOGICAL AND ENDOCRINE CONSEQUENCES OF IMMUNE ACTIVITY

[1] ABO T, 1981, J IMMUNOL, V126, P1360

[2] EFFECT OF HYPOTHALAMIC-LESIONS ON EXPERIMENTAL AUTOIMMUNE-DISEASES IN RATS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 496 : 360 - 365

[3] NEUROPSYCHIATRIC MANIFESTATIONS OF HUMAN-LEUKOCYTE INTERFERON THERAPY IN PATIENTS WITH CANCER [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (07): : 938 - 941

[4] BEHAVIORALLY CONDITIONED IMMUNOSUPPRESSION [J]. PSYCHOSOMATIC MEDICINE, 1975, 37 (04): : 333 - 340

[5] Ader R., 1981, PSYCHONEUROIMMUNOLOG, V1st ed.

[6] ADLER D, 1987, INT J NEUROSCI, V21, P989

[7] AHLQVIST J, 1981, PSYCHONEUROIMMUNOLOG, P355

[8] HYPOTHALAMIC CONTROL OF ADRENOCORTICOTROPIN SECRETION - ADVANCES SINCE THE DISCOVERY OF 41-RESIDUE CORTICOTROPIN-RELEASING FACTOR [J]. ENDOCRINE REVIEWS, 1986, 7 (04) : 351 - 378

[9] BEAUMONT A, 1979, ANN REV IMMUNOL TOXI, V9, P245

[10] BERKENBOSCH F, 1988, IN PRESS SCIENCE

[1] ABO T, 1981, J IMMUNOL, V126, P1360

[2] EFFECT OF HYPOTHALAMIC-LESIONS ON EXPERIMENTAL AUTOIMMUNE-DISEASES IN RATS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 496 : 360 - 365

[3] NEUROPSYCHIATRIC MANIFESTATIONS OF HUMAN-LEUKOCYTE INTERFERON THERAPY IN PATIENTS WITH CANCER [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (07): : 938 - 941

[4] BEHAVIORALLY CONDITIONED IMMUNOSUPPRESSION [J]. PSYCHOSOMATIC MEDICINE, 1975, 37 (04): : 333 - 340

[5] Ader R., 1981, PSYCHONEUROIMMUNOLOG, V1st ed.

[6] ADLER D, 1987, INT J NEUROSCI, V21, P989

[7] AHLQVIST J, 1981, PSYCHONEUROIMMUNOLOG, P355

[8] HYPOTHALAMIC CONTROL OF ADRENOCORTICOTROPIN SECRETION - ADVANCES SINCE THE DISCOVERY OF 41-RESIDUE CORTICOTROPIN-RELEASING FACTOR [J]. ENDOCRINE REVIEWS, 1986, 7 (04) : 351 - 378

[9] BEAUMONT A, 1979, ANN REV IMMUNOL TOXI, V9, P245

[10] BERKENBOSCH F, 1988, IN PRESS SCIENCE